9th Nov 2020 16:24
RTW Venture Fund Ltd - New York-based investment company which invests in life sciences, biopharmaceutical, and medical technology companies - RTW co-leads USD130 million financing round in Prometheus Biosciences, a US private biotechnology firm. "The company's investment in Prometheus is its eleventh portfolio company addition following its IPO in October 2019," RTW said.
Current stock price: USD1.65
Year-to-date change: down 20%
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Rtw Biotech